Skip to main content
OpenTrials
Completed

NCT Number: NCT02314520

Complications Associated With Central Venous Access in the NSICU: PICC vs CVC

The goal of this study is to determine whether Peripherally Inserted Central Catheter or Centrally Inserted Venous Catheters have lower complication rates in the Neuroscience Intensive Care Unit. After admission to the Neuroscience ICU and if they require central access, patients will be randomized to receive a PICC or CVC and complications (such as pneumothorax, deep venous thrombosis, infection, etc.) will be tracked and compared between the two interventions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

PICC CVC Central Line Central Venous Catheter Neuro ICU Neuroscience ICU

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Penn State Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients admitted to the NSICU, who require central access for the treatment of their illness.

Exclusion criteria

  • Current or recent (within 1 month) diagnosis of bacteremia
  • Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis
  • Existing central access
  • Non-English speaking
  • Requirement for emergent central access and unable to obtain consent in an emergency setting

Treatment and study plan

Peripherally Inserted Central Catheter

Device

Any complication associated with central access

centrally inserted central catheter

Device

Central access not associated with any complication

Primary outcomes

  1. Participants With Complications With Central Access Including Insertion

    Time frame: up to 10 weeks

    Aggregation of all complications associated with central access including insertion

Secondary outcomes

  1. Number of Participants With Deep Venous Thrombosis

    Time frame: up to 10 weeks

  2. Number of Patients With Complications Related to Insertion

    Time frame: From the time of insertion until first confirmatory chest X-ray

    Any complication of insertion including technical failure

  3. Number of Participants With a Central Line Associated Blood Stream Infection

    Time frame: up to 10 weeks

    A Central access associated infection (CLABSI)

Sponsors and collaborators

Lead sponsor

Milton S. Hershey Medical Center

Other

Registry information

Acronym: NSPVC

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Dec 11, 2014
Registry last updated
Jul 19, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.